Full Content is available to subscribers

Subscribe/Learn More  >
Proceedings Article

Laser immunotherapy for the treatment of human breast cancer: one-year follow up results

[+] Author Affiliations
Tomas Hode, Maria C. Guerra

Immunophotonics, Inc. (USA)

Orn Adalsteinsson

International Strategic Cancer Alliance (USA)

Gabriela L. Ferrel

Hospital Nacional Edgardo Rebagliati Martins (Peru)

John A. Lunn

Commonwealth Medical Research Institute (Bahamas)

Xiaosong Li

First Affiliated Hospital of Chinese PLA General Hospital (China)

Robert E. Nordquist

Immunophotonics, Inc.. (USA)

Wei R. Chen

Univ. of Central Oklahoma (USA)

Proc. SPIE 7900, Biophotonics and Immune Responses VI, 790009 (February 23, 2011); doi:10.1117/12.874798
Text Size: A A A
From Conference Volume 7900

  • Biophotonics and Immune Responses VI
  • Wei R. Chen
  • San Francisco, California, USA | January 22, 2011

abstract

The immediate goal of the trial was to determine the breast cancer patient tolerance and the toxicity of Laser immunotherapy (LIT), the optimal dose for the alteration of the course of the disease, and the reduction of the tumor burden. Ten stage III and IV cancer patients were treated, all of which were considered to be out of all other options. No toxicity or significant adverse reactions were observed and the treatment was well tolerated by all patients. Almost all the treated patients have had positive responses: A majority of patients experienced large-scale reduction of primary breast tumors, and all the stage IV patients experienced either complete or significant reductions in distant metastases in the lungs, liver, bone, and the brain, indicating a strong systemic effect of the treatment. We also report two cases of triple negative breast cancer patients that showed limited or no response to LIT.

© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation

Tomas Hode ; Orn Adalsteinsson ; Gabriela L. Ferrel ; John A. Lunn ; Maria C. Guerra, et al.
"Laser immunotherapy for the treatment of human breast cancer: one-year follow up results", Proc. SPIE 7900, Biophotonics and Immune Responses VI, 790009 (February 23, 2011); doi:10.1117/12.874798; http://dx.doi.org/10.1117/12.874798


Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).

Figures

Tables

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Book Chapters

Topic Collections

Advertisement


 

  • Don't have an account?
  • Subscribe to the SPIE Digital Library
  • Create a FREE account to sign up for Digital Library content alerts and gain access to institutional subscriptions remotely.
Access This Proceeding
Sign in or Create a personal account to Buy this proceeding ($15 for members, $18 for non-members).
Access This Proceeding
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
Access This Chapter

Access to SPIE eBooks is limited to subscribing institutions and is not available as part of a personal subscription. Print or electronic versions of individual SPIE books may be purchased via SPIE.org.